Serial #79408867
LIVE

Serial Number

79408867

Owner

Meteor Biotech Co., Ltd.

Attorney

Minchul Yang

Filing Date

May 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79408867 Trademark

Serial Number: 79408867 • Registration: 7963149

Serial #79408867 is a trademark filed by Meteor Biotech Co., Ltd. on May 29, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Meteor Biotech Co., Ltd. (5 trademarks)

(Sillimdong) 401, 117, Sillim-ro, Gwanak-gu

Entity Type: 03

Trademark Details

Filing Date

May 29, 2024

Registration Date

September 30, 2025

Published for Opposition

August 12, 2025

Goods & Services

Diagnostic reagents for scientific use; Reagents for scientific purposes for use in nucleic acid amplifications; Markers being reagents for scientific purposes for use in analyzing nucleic acid; Reagents for scientific purposes for use in extracting nucleic acid; Chemical reagents for use in nucleic acid amplifications, other than for medical or veterinary purposes; Chemical reagents for use in extracting nucleic acid, other than for medical or veterinary purposes; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Reagents for scientific use

Diagnostic apparatus for research laboratory use for DNA analysis; Laboratory devices for DNA sequencing, not for medical purposes; Laboratory devices for analyzing polynucleic acid, not for medical purposes; Reagent containers being chips having multi-well arrays for use with protein analysis apparatus used in chemical analysis and biological analysis for laboratory research use; Laboratory devices for analyzing and extracting genes, not for medical purposes; Laboratory apparatus and instruments for preparing nucleic acid samples; Diagnostic chips being bio-chips for analyzing blood plasma for laboratory use; Laboratory apparatus, namely, devices for analyzing protein sequences, not for medical purposes; Scientific apparatus, namely, diagnostic apparatus for research laboratory use for analyzing genes

Wholesale store services featuring chemicals for analyzing nucleic acid for scientific or laboratory purposes; Computerized database management; Retail store services featuring medical apparatus and instruments other than for dental purposes; Retail store services featuring chemicals for analyzing nucleic acid for scientific or laboratory purposes; Wholesale store services featuring pharmaceutical products for humans and animals; Retail store services featuring pharmaceutical products for humans and animals; Wholesale store services featuring chemical preparations for use in industry; Retail store services featuring chemical preparations for use in industry

Medical analysis for the diagnosis and treatment of persons; Medical laboratory analysis services relating to the treatment of persons; Medical services relating to the removal, treatment and processing of human blood; RNA or DNA analysis being medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of cancer; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Provision of genetic testing for medical purposes; Provision of information for medical purposes in the field of gene therapy for cancer treatment; Medical diagnostic services; medical screening; Genetic counseling

Biomarker discovery services being medical research; Medical diagnostic services using biomarker analysis; Selection and screening of biomarkers in biological tissue samples for scientific research purposes; Scientific research for medical purposes in the area of cancerous diseases; Consulting business, namely, consulting services in the field of biological sequence processing and analysis for medical research purposes; Research in the field of gene expression analysis; Development of computer software for use with medical equipment; Providing computer software technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; Product development in the field of medical diagnostic devices; Blood testing business, namely, blood testing for medical research purposes

Reagents for medical use; Drugs for medical purposes, namely, acetaminophen; Enzymes for medical purposes; Enzyme preparations for medical purposes; Nucleic acid sequences for medical and veterinary purposes; Diagnostic chemical preparations for medical purposes for use in DNA analysis; In vitro diagnostic preparations for medical purposes; Diagnostic test reagents for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Reagents for use in medical genetic testing

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 30, 2026 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 23, 2026 OPNX
LIMITATION OF GOODS RECEIVED FROM IB
Apr 16, 2026 LIMG
FINAL DISPOSITION NOTICE SENT TO IB
Apr 9, 2026 FICS
FINAL DISPOSITION PROCESSED
Apr 9, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 6, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 6, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 30, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 30, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 12, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 12, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 6, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 5, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 5, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 5, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 5, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 5, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2025 TROA
REFUSAL PROCESSED BY IB
Jan 17, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 2, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jan 2, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 14, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 13, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 10, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 8, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 7, 2024 REPR